Utilizing immunohistochemistry staining, we investigated the expression of SIGLEC7 in glioma tissues, with results consistent with RNA sequencing data, indicating an enriched expression of SIGLEC7 in higher-grade glioma tissues (Figure 7A). The gene discussed is SIGLEC7; the disease is central nervous system cancer.